Myocarditis in Children

Heart Failure Clinics

Volumn 6, Issue 4, 2010, Pages 483-496

  Kühl, Uwe ^a   Schultheiss, Heinz Peter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Coxsackie adenoviral receptor; Heart failure; Inflammatory cardiomyopathy; Lymphocytic myocarditis; Myocardial cell loss; Viral myocarditis

Indexed keywords

5 [5 [2,6 DICHLORO 4 (4,5 DIHYDRO 2 OXAZOLYL)PHENOXY]PENTYL] 3 METHYLISOXAZOLE; AZATHIOPRINE; CORTISONE; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; CYCLOSPORIN; IMMUNOGLOBULIN; PLECONARIL;

ADENOVIRUS; ANTIVIRAL THERAPY; CLINICAL FEATURE; ENTEROVIRUS; HEART FAILURE; HEART MUSCLE BIOPSY; HUMAN; HUMAN HERPESVIRUS 6; HUMAN PARVOVIRUS B19; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; MYOCARDITIS; NON INVASIVE PROCEDURE; PATHOPHYSIOLOGY; PEDIATRIC CARDIOLOGY; PROGNOSIS; REVIEW; SUDDEN INFANT DEATH SYNDROME; SYSTEMIC DISEASE; VIRUS MYOCARDITIS;

ACUTE DISEASE; ANTI-INFLAMMATORY AGENTS; ANTIVIRAL AGENTS; BIOPSY; CARDIOMYOPATHY, DILATED; CHILD; CREATINE KINASE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ENDOCARDIUM; HEART FAILURE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MAGNETIC RESONANCE IMAGING, CINE; MYOCARDITIS; PROGNOSIS; TROPONIN;

EID: 77956942621     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2010.05.009     Document Type: Review

References (121)

1. Liu P.P., Schultheiss H.P. Myocarditis. Baunwald's heart disease a textbook of cardiovascular medicine 2008, 1775-1792. WB Saunders, Philadelphia. 8th edition. P. Libby, R.O. Bonow, D.L. Mann (Eds.).
2. Aretz H.T., Billingham M.E., Edwards W.D., et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1987, 1:3-14.
3. Kleinert S., Weintraub R.G., Wilkinson J.L., et al. Myocarditis in children with dilated cardiomyopathy: incidence and outcome after dual therapy immunosuppression. J Heart Lung Transplant 1997, 16:1248-1254.
4. Laufs H., Nigrovic P.A., Schneider L.C., et al. Giant cell myocarditis in a 12-year-old girl with common variable immunodeficiency. Mayo Clin Proc 2002, 77:92-96.
5. Lind-Ayres M.R., Abramowsky C., Mahle W.T. Pediatric giant cell myocarditis and orbital myositis. Pediatr Cardiol 2009, 30:510-512.
6. Cooper L.T. Giant cell myocarditis in children. Prog Pediatr Cardiol 2007, 24:47-49.
7. Kodama M., Oda H., Okabe M., et al. Early and long-term mortality of the clinical subtypes of myocarditis. Jpn Circ J 2001, 65:961-964.
8. Gagliardi M.G., Bevilacqua M., Squitieri C., et al. Dilated cardiomyopathy caused by acute myocarditis in pediatric patients: evolution of myocardial damage in a group of potential heart transplant candidates. J Heart Lung Transplant 1993, 12:S224-S229.
9. Kühl U., Noutsias M., Seeberg B., et al. Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. Heart 1996, 75:295-300.
10. Kuhl U., Schultheiss H.P. Viral myocarditis: diagnosis, aetiology and management. Drugs 2009, 69:1287-1302.
11. Mason J.W. Myocarditis and dilated cardiomyopathy: an inflammatory link. Cardiovasc Res 2003, 60:5-10.
12. Bergelson J.M., Cunningham J.A., Droguett G., et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997, 275:1320-1323.
13. Bergelson J.M. Receptors mediating adenovirus attachment and internalization. Biochem Pharmacol 1999, 57:975-979.
14. Noutsias M., Fechner H., de Jonge H., et al. Human coxsackie-adenovirus receptor is colocalized with integrins alpha(v)beta(3) and alpha(v)beta(5) on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy: implications for cardiotropic viral infections. Circulation 2001, 104:275-280.
15. Bultmann B.D., Klingel K., Sotlar K., et al. Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. Hum Pathol 2003, 34:92-95.
16. Bock C.T., Klingel K., Aberle S., et al. Human Parvovirus B19: a new emerging pathogen of inflammatory cardiomyopathy. J Vet Med B Infect Dis Vet Public Health 2005, 52:340-343.
17. Klingel K., Sauter M., Bock C.T., et al. Molecular pathology of inflammatory cardiomyopathy. Med Microbiol Immunol (Berl) 2004, 193:101-107.
18. Hilton D.A., Variend S., Pringle J.H. Demonstration of Coxsackie virus RNA in formalin-fixed tissue sections from childhood myocarditis cases by in situ hybridization and the polymerase chain reaction. J Pathol 1993, 170:45-51.
19. Liu P.P., Opavsky M.A. Viral myocarditis: receptors that bridge the cardiovascular with the immune system?. Circ Res 2000, 86:253-254.
20. Levi D., Alejos J. Diagnosis and treatment of pediatric viral myocarditis. Curr Opin Cardiol 2001, 16:77-83.
21. Gravanis M.B., Sternby N.H. Incidence of myocarditis. A 10-year autopsy study from Malmo, Sweden. Arch Pathol Lab Med 1991, 115:390-392.
22. Mason J.W. Immunopathogenesis and treatment of myocarditis: the United States Myocarditis Treatment Trial. J Card Fail 1996, 2:S173-S177.
23. Doolan A., Langlois N., Semsarian C. Causes of sudden cardiac death in young Australians. Med J Aust 2004, 180:110-112.
24. Kyto V., Saraste A., Voipio-Pulkki L.M., et al. Incidence of fatal myocarditis: a population-based study in Finland. Am J Epidemiol 2007, 165:570-574.
25. Webber S.A., Boyle G.J., Jaffe R., et al. Role of right ventricular endomyocardial biopsy in infants and children with suspected or possible myocarditis. Br Heart J 1994, 72:360-363.
26. Towbin J.A., Lowe A.M., Colan S.D., et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 2006, 296:1867-1876.
27. Camargo P.R., Okay T.S., Yamamoto L., et al. Myocarditis in children and detection of viruses in myocardial tissue: implications for immunosuppressive therapy. Int J Cardiol 2009, [Epub ahead of print].
28. Durani Y., Egan M., Baffa J., et al. Pediatric myocarditis: presenting clinical characteristics. Am J Emerg Med 2009, 27:942-947.
29. Nugent A.W., Daubeney P.E., Chondros P., et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 2003, 348:1639-1646.
30. Wilkinson J.D., Sleeper L.A., Alvarez J.A., et al. The pediatric cardiomyopathy registry: 1995-2007. Prog Pediatr Cardiol 2008, 25:31-36.
31. Cox G.F., Sleeper L.A., Lowe A.M., et al. Factors associated with establishing a causal diagnosis for children with cardiomyopathy. Pediatrics 2006, 118:1519-1531.
32. Lipshultz S.E., Sleeper L.A., Towbin J.A., et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 2003, 348:1647-1655.
33. Weber M.A., Ashworth M.T., Risdon R.A., et al. Clinicopathological features of paediatric deaths due to myocarditis: an autopsy series. Arch Dis Child 2008, 93:594-598.
34. Calabrese F., Rigo E., Milanesi O., et al. Molecular diagnosis of myocarditis and dilated cardiomyopathy in children: clinicopathologic features and prognostic implications. Diagn Mol Pathol 2002, 11:212-221.
35. Bowles N.E., Kearney D.L., Ni J., et al. The detection of viral genomes by polymerase chain reaction in the myocardium of pediatric patients with advanced HIV disease. J Am Coll Cardiol 1999, 34:857-865.
36. Bowles N.E., Ni J., Kearney D.L., et al. Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 2003, 42:466-472.
37. Carturan E., Milanesi O., Kato Y., et al. Viral detection and tumor necrosis factor alpha profile in tracheal aspirates from children with suspicion of myocarditis. Diagn Mol Pathol 2008, 17:21-27.
38. Comar M., D'Agaro P., Campello C., et al. Human herpes virus 6 in archival cardiac tissues from children with idiopathic dilated cardiomyopathy or congenital heart disease. J Clin Pathol 2009, 62:80-83.
39. Dettmeyer R., Baasner A., Schlamann M., et al. Coxsackie B3 myocarditis in 4 cases of suspected sudden infant death syndrome: diagnosis by immunohistochemical and molecular-pathologic investigations. Pathol Res Pract 2002, 198:689-696.
40. Gouton M., Di Filippo S., Sassolas F., et al. Arch Mal Coeur Vaiss 1995, 88:753-759. [in French].
41. Martin A.B., Webber S., Fricker F.J., et al. Acute myocarditis. Rapid diagnosis by PCR in children. Circulation 1994, 90:330-339.
42. Munro K., Croxson M.C., Thomas S., et al. Three cases of myocarditis in childhood associated with human parvovirus (B19 virus). Pediatr Cardiol 2003, 24:473-475.
43. Savon C., Acosta B., Valdes O., et al. A myocarditis outbreak with fatal cases associated with adenovirus subgenera C among children from Havana City in 2005. J Clin Virol 2008, 43:152-157.
44. Schowengerdt K.O., Ni J., Denfield S.W., et al. Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reaction. Circulation 1997, 96:3549-3554.
45. Talsma M.D., Kroos M.A., Visser G., et al. A rare presentation of childhood pompe disease: cardiac involvement provoked by Epstein-Barr virus infection. Pediatrics 2002, 109:e65.
46. Vare D., Vare B., Dauphin C., et al. Arch Mal Coeur Vaiss 2000, 93:571-579. [in French].
47. Baboonian C., Treasure T. Meta-analysis of the association of enteroviruses with human heart disease. Heart 1997, 78:539-543.
48. Batmaz G., Villain E., Bonnet D., et al. Arch Mal Coeur Vaiss 2000, 93:553-557. [in French].
49. Dancea A.B. Myocarditis in infants and children: a review for the paediatrician. Paediatr Child Health 2001, 6:543-545.
50. Khaleduzzaman M., Francis J., Corbin M.E., et al. Infection of cardiomyocytes and induction of left ventricle dysfunction by neurovirulent polytropic murine retrovirus. J Virol 2007, 81:12307-12315.
51. Guarner J., Paddock C.D., Shieh W.J., et al. Histopathologic and immunohistochemical features of fatal influenza virus infection in children during the 2003-2004 season. Clin Infect Dis 2006, 43:132-140.
52. Costello J.M., Alexander M.E., Greco K.M., et al. Lyme carditis in children: presentation, predictive factors, and clinical course. Pediatrics 2009, 123:e835-e841.
53. Taliercio C.P., Olney B.A., Lie J.T. Myocarditis related to drug hypersensitivity. Mayo Clin Proc 1985, 60:463-468.
54. Press S., Lipkind R.S. Acute myocarditis in infants. Initial presentation. Clin Pediatr (Phila) 1990, 29:73-76.
55. Amvrosieva T.V., Paklonskaya N.V., Biazruchka A.A., et al. Enteroviral infection outbreak in the Republic of Belarus: principal characteristics and phylogenetic analysis of etiological agents. Cent Eur J Public Health 2006, 14:67-73.
56. Mounts A.W., Amr S., Jamshidi R., et al. A cluster of fulminant myocarditis cases in children, Baltimore, Maryland, 1997. Pediatr Cardiol 2001, 22:34-39.
57. Schoub B.D., Johnson S., McAnerney J.M., et al. Epidemic Coxsackie B virus infection in Johannesburg, South Africa. J Hyg (Lond) 1985, 95:447-455.
58. Valdes O., Acosta B., Pinon A., et al. First report on fatal myocarditis associated with adenovirus infection in Cuba. J Med Virol 2008, 80:1756-1761.
59. Wang D.M., Zhao G.C., Zhuang S.M., et al. An epidemic of encephalitis and meningoencephalitis in children caused by echovirus type 30 in Shanghai. Chin Med J (Engl) 1993, 106:767-769.
60. Yodfat Y., Nishmi M. Clinical virology in family practice: epidemiological and clinical observations of an outbreak of Coxsackievirus B type 1 infection in a kibbutz. J Fam Pract 1977, 5:201-207.
61. Zurynski Y.A., Lester-Smith D., Festa M.S., et al. Enhanced surveillance for serious complications of influenza in children: role of the Australian Paediatric Surveillance Unit. Commun Dis Intell 2008, 32:71-76.
62. Adekanmbi A.F., Ogunlesi T.A., Olowu A.O., et al. Current trends in the prevalence and aetiology of childhood congestive cardiac failure in Sagamu. J Trop Pediatr 2007, 53:103-106.
63. Chehab G., Shalak W., Gerbaka B., et al. J Med Liban 2006, 54:124-131. [in French].
64. Rajs J., Hammarquist F. Sudden infant death in Stockholm. A forensic pathology study covering ten years. Acta Paediatr Scand 1988, 77:812-820.
65. Dettmeyer R., Baasner A., Schlamann M., et al. Role of virus-induced myocardial affections in sudden infant death syndrome: a prospective postmortem study. Pediatr Res 2004, 55:947-952.
66. Woodruff J.F. Viral myocarditis. A review. Am J Pathol 1980, 101:425-484.
67. Chang Y.J., Chao H.C., Hsia S.H., et al. Myocarditis presenting as gastritis in children. Pediatr Emerg Care 2006, 22:439-440.
68. Chavda K.K., Dhuper S., Madhok A., et al. Seizures secondary to a high-grade atrioventricular block as a presentation of acute myocarditis. Pediatr Emerg Care 2004, 20:387-390.
69. da Silva M.A., da Silva R.P., de Morais S.C., et al. Arq Bras Cardiol 1991, 56:213-218. [in Portuguese].
70. Nugent A.W., Davis A.M., Kleinert S., et al. Clinical, electrocardiographic, and histologic correlations in children with dilated cardiomyopathy. J Heart Lung Transplant 2001, 20:1152-1157.
71. Mangnani J.W., Dec G.W. Myocarditis: current trends in diagnosis and treatment. Circulation 2006, 113:876-890.
72. Morgera T., Di Lenarda A., Dreas L., et al. Electrocardiography of myocarditis revisited: clinical and prognostic significance of electrocardiographic changes. Am Heart J 1992, 124:455-467.
73. Smith S.C., Ladenson J.H., Mason J.W., et al. Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation 1997, 95:163-168.
74. Soongswang J., Durongpisitkul K., Nana A., et al. Cardiac troponin T: a marker in the diagnosis of acute myocarditis in children. Pediatr Cardiol 2005, 26:45-49.
75. Pinamonti B., Alberti E., Cigalotto A., et al. Echocardiographic findings in myocarditis. Am J Cardiol 1988, 62:285-291.
76. Abdel-Aty H., Boye P., Zagrosek A., et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 2005, 45:1815-1822.
77. Friedrich M.G., Sechtem U., Schulz-Menger J., et al. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol 2009, 53:1475-1487.
78. Vashist S., Singh G.K. Acute myocarditis in children: current concepts and management. Curr Treat Options Cardiovasc Med 2009, 11:383-391.
79. Gutberlet M., Spors B., Thoma T., et al. Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology 2008, 246:401-409.
80. Balaji S., Wiles H.B., Sens M.A., et al. Immunosuppressive treatment for myocarditis and borderline myocarditis in children with ventricular ectopic rhythm. Br Heart J 1994, 72:354-359.
81. Baughman K.L. Diagnosis of myocarditis: death of Dallas criteria. Circulation 2006, 113:593-595.
82. Schultheiss H.P., Kuehl U. Cardiovascular viral infections. Lennette's laboratory diagnosis of viral infections 2010, 304-318. Informa Healthcare, New York (NY), Chapter 18. 4th edition. E.H. Lennette (Ed.).
83. Celiker A., Ozkutlu S., Ozer S., et al. Endomyocardial biopsy in children. Usefulness in various myocardial disorders. Jpn Heart J 1991, 32:227-237.
84. Chandra R.S. The role of endomyocardial biopsy in the diagnosis of cardiac disorders in infants and children. Am J Cardiovasc Pathol 1987, 1:157-172.
85. Gagliardi M.G., Bevilacqua M., Parisi F., et al. G Ital Cardiol 1992, 22:963-968. [in Italian].
86. Narula N., Narula J., Dec G.W. Endomyocardial biopsy for non-transplant-related disorders. Am J Clin Pathol 2005, 123(Suppl):S106-S118.
87. Schmaltz A.A., Apitz J., Hort W. Endomyocardial biopsy in infants and children: technique; indications and results. Eur J Pediatr 1982, 138:211-215.
88. Cowley C.G., Lozier J.S., Orsmond G.S., et al. Safety of endomyocardial biopsy in children. Cardiol Young 2003, 13:404-407.
89. Pass R.H., Trivedi K.R., Hsu D.T. A new technique for endomyocardial biopsy in infants and small children. Catheter Cardiovasc Interv 2000, 50:441-444.
90. Schmaltz A.A., Apitz J., Hort W., et al. Z Kardiol 1987, 76:563-569. [in German].
91. Yoshizato T., Edwards W.D., Alboliras E.T., et al. Safety and utility of endomyocardial biopsy in infants, children and adolescents: a review of 66 procedures in 53 patients. J Am Coll Cardiol 1990, 15:436-442.
92. Parisi F. Why do we not perform routine endomyocardial biopsies in childhood cardiomyopathy?. J Heart Lung Transplant 2009, 28(12):1249-1251.
93. Holzmann M., Nicko A., Kühl U., et al. Complication rate of right ventricular endomyocardial biopsy via the femoral approach. A retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period. Circulation 2008, 118:1722-1728.
94. Frustaci A., Russo M.A., Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 2009, 30:1995-2002.
95. Kühl U., Strauer B.E., Schultheiss H.P. Methylprednisolone in chronic myocarditis. Postgrad Med J 1994, 70:S35-S42.
96. Wojnicz R., Nowalany-Kozielska E., Wojciechowska C., et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 2001, 104:39-45.
97. Drucker N.A., Colan S.D., Lewis A.B., et al. Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation 1994, 89:252-257.
98. English R.F., Janosky J.E., Ettedgui J.A., et al. Outcomes for children with acute myocarditis. Cardiol Young 2004, 14:488-493.
99. Klugman D., Berger J.T., Sable C.A., et al. Pediatric patients hospitalized with myocarditis: a multi-institutional analysis. Pediatr Cardiol 2009, 31(2):222-228.
100. Chan K.Y., Iwahara M., Benson L.N., et al. Immunosuppressive therapy in the management of acute myocarditis in children: a clinical trial. J Am Coll Cardiol 1991, 17:458-460.
101. Nunes T., Vaz T., Monterroso J., et al. Rev Port Cardiol 1991, 10:511-516. [in Portuguese].
102. Camargo P.R., Snitcowsky R., da Luz P.L., et al. Favorable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis. Pediatr Cardiol 1995, 16:61-68.
103. Frustaci A., Chimenti C., Calabrese F., et al. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 2003, 107:857-863.
104. Khatib R., Reyes M.P., Smith F., et al. Enhancement of coxsackievirus B4 virulence by indomethacin. J Lab Clin Med 1990, 116:116-120.
105. Costanzo-Nordin M.R., Reap E.A., O'Connell J.B., et al. A nonsteroid anti-inflammatory drug exacerbates Coxsackie B3 murine myocarditis. J Am Coll Cardiol 1985, 6:1078-1082.
106. Abzug M.J. Presentation, diagnosis, and management of enterovirus infections in neonates. Paediatr Drugs 2004, 6:1-10.
107. Liu Z., Yuan J., Yanagawa B., et al. Coxsackievirus-induced myocarditis: new trends in treatment. Expert Rev Anti Infect Ther 2005, 3:641-650.
108. Kühl U., Pauschinger M., Schwimmbeck P.L., et al. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 2003, 107:2793-2798.
109. Schmidt-Lucke C., Spillmann F., Bock T., et al. Interferon-beta modulates endothelial damage in patients with cardiac persistence of human parvovirus b19 infection. J Infect Dis 2009, 201(6):936-945.
110. Stanton C., Mookadam F., Cha S., et al. Greater symptom duration predicts response to immunomodulatory therapy in dilated cardiomyopathy. Int J Cardiol 2008, 128:38-41.
111. McCarthy R.E., Boehmer J.P., Hruban R.H., et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000, 342:690-695.
112. Torres F., Anguita M., Tejero I., et al. Rev Esp Cardiol 1995, 48:660-665. [in Spanish].
113. Lee K.J., McCrindle B.W., Bohn D.J., et al. Clinical outcomes of acute myocarditis in childhood. Heart 1999, 82:226-233.
114. Rajagopal S.K., Almond C.S., Laussen P.C., et al. Extracorporeal membrane oxygenation for the support of infants, children, and young adults with acute myocarditis: a review of the Extracorporeal Life Support Organization registry. Crit Care Med 2009, 38(2):382-387.
115. Duncan B.W., Bohn D.J., Atz A.M., et al. Mechanical circulatory support for the treatment of children with acute fulminant myocarditis. J Thorac Cardiovasc Surg 2001, 122:440-448.
116. Stiller B., Weng Y., Hubler M., et al. Pneumatic pulsatile ventricular assist devices in children under 1 year of age. Eur J Cardiothorac Surg 2005, 28:234-239.
117. Matitiau A., Perez-Atayde A., Sanders S.P., et al. Infantile dilated cardiomyopathy. Relation of outcome to left ventricular mechanics, hemodynamics, and histology at the time of presentation. Circulation 1994, 90:1310-1318.
118. Parisi F., Carotti A., Esu F., et al. Intermediate and long-term results after pediatric heart transplantation: incidence and role of pretransplant diagnosis. Transpl Int 1998, 11(Suppl 1):S493-S498.
119. Amabile N., Fraisse A., Bouvenot J., et al. Outcome of acute fulminant myocarditis in children. Heart 2006, 92:1269-1273.
120. Bohn D., Benson L. Diagnosis and management of pediatric myocarditis. Paediatr Drugs 2002, 4:171-181.
121. Kirk R., Naftel D., Hoffman T.M., et al. Outcome of pediatric patients with dilated cardiomyopathy listed for transplant: a multi-institutional study. J Heart Lung Transplant 2009, 28(12):1322-1328.